ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
Today Allergan Aesthetics, an AbbVie company, announces the sixth consecutive year of partnership with Girls Inc. The partnership supports high school and college girls' interest in STEM and mentorship.
AbbVie (ABBV) closed the most recent trading day at $195.45, moving -0.7% from the previous trading session.